In the present study, we demonstrated that tiotropium bromide improved bronchoconstriction, and that it significantly reduced the concentrations of IL-5, IL-6, IL-13, and KC/CXCL1 in BALF, and subsequently led to reduced neutrophilic airway inflammation in a mouse model of OVA-induced asthma. Here, IL5 is linked to asthma.